“Patients should speak with their healthcare provider about concerns and other treatment options,” the FDA website says. The Food and Drug Administration announced a Class II recall of more than 7,000 bottles of an antidepressant due to a chemical. The recall was initiated earlier this month on October 10th. According to the Cleveland Clinic, duloxetine, […]